PIMC - Lease of Clinical Chemistry/Immuno-Chemistry Equipment, Service Agreement, & Supplies
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
*THIS IS A SOURCES SOUGHT ONLY. DO NOT SUBMIT PRICING INFORMATION*
PIMC has a need to implement a Clinical Chemistry/Immuno-Chemistry Instrumentation system with an automated platform to perform general chemistry, special chemistry, immunology, serology, hepatitis, infectious disease, therapeutic drug monitoring and toxicology patient tests, cancer, fertility and other test menu/assays. The clinical diagnostic platform will allow PIMC to meet patient needs while maintaining accreditation and reduce cost of using reference laboratories
The Contractor shall provide all testing equipment at no cost to the Government and shall be an all-inclusive cost to include, but not limited to, all supplies, reagents/consumables, preventive maintenance, off-site training, and service agreement. The continuous analytical testing shall be performed using serum, plasma, urine and/or body fluids for immunoassays, quantitative/qualitative clinical chemistry, enzymatic and rate-based analysis of patient sample constituents for the purpose of diagnosing and treating patients at the PIMC Laboratory.
*DO NOT SUBMIT A QUOTE OR ANY PRICING INFORMATION TO THIS NOTICE*